Sober sitter or coconsumer? Psychedelics, online forums and preferences for interpersonal interactions
Sascha Thal, Liam Engel, Stephen Bright
Addiction Research & Theory May 6, 2022 DOI: 10.1080/16066359.2022.2065268 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Population | Posts from the psychedelic forums The Shroomery and The DMT Nexus |
| Key findings | Psychedelic consumers prefer nonintrusive interactions, boundary setting, help, and a sober sitter or coconsumer, with additional desires for agency, co-consumption, and carers with personal psychedelic experience that diverge from clinical guidelines. |
Abstract
Abstract Contemporary clinical research into the psychotherapeutic administration of psychedelics has primarily emphasized the importance of therapeutic interpersonal interactions to assist clients prepare for and integrate the acute effects of psychedelics. Alternative therapeutic frameworks have encouraged active talk therapy between therapists and clients during the administration phase. We used data gathered from forums to investigate consumer preferences concerning interpersonal interactions during their psychedelic-occasioned experience. Google was used to locate relevant posts on the psychedelic forums The Shroomery and The DMT Nexus. We analyzed these posts using thematic analysis, in which two researchers independently categorized posts in accordance with emergent themes. These themes were then refined through iterative reflexivity. We then identified four themes pertaining to psychedelic consumer interpersonal interaction preferences: nonintrusive; boundary setting; help; and sober sitter or coconsumer. Further analysis revealed parallels between consumer preferences and clinical guidelines for psychedelic-assisted psychotherapy, including the emphasis of carer acceptance; minimal involvement; nondirection; hazard management and emotional stability. However, there was also disparity between consumer preferences and guidelines, specifically concerning desires for consumer agency; for psychedelic consumption alongside other consumers, and for carers who had consumed psychedelics themselves. These findings have clinical implications and thus may aid the development of future guidelines.
Citations in the library
Cited by 7
- Psychedelic-assisted psychotherapy: where is the psychotherapy research? Psychopharmacology August 1, 2024
- Psychedelic Forum Member Preferences for Carer Experience and Consumption Behavior: Can “Trip Sitters” Help Inform Psychedelic Harm Reduction Services? Contemporary Drug Problems August 29, 2022
- Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review Journal of Psychopharmacology October 20, 2022
- Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports Journal of Psychedelic Studies July 17, 2024
- The Psychedelic Social Club: a regulatory concept for people who use psychedelics? Drugs Education Prevention and Policy October 30, 2023
and 2 more in the library
Cites 28
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Frontiers in Pharmacology January 17, 2018
- Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Journal of Psychopharmacology August 31, 2016
- Predicting Responses to Psychedelics: A Prospective Study Frontiers in Pharmacology November 2, 2018
- Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature BMC Psychiatry July 31, 2018
and 23 more in the library